TERT promoter mutations are associated with distant metastases in papillary thyroid carcinoma.
about
Cancer-Specific Telomerase Reverse Transcriptase (TERT) Promoter Mutations: Biological and Clinical ImplicationsTERT promoter mutations in thyroid cancerMutation Profile of Well-Differentiated Thyroid Cancer in AsiansA meta-analysis of prognostic roles of molecular markers in papillary thyroid carcinomaThe correlations between DNA methylation and polymorphisms in the promoter region of the human telomerase reverse transcriptase (hTERT) gene with postoperative recurrence in patients with thyroid carcinoma (TC).TERT Promoter Mutations Are Predictive of Aggressive Clinical Behavior in Patients with Spitzoid Melanocytic Neoplasms.Clinical Characteristics and Prognostic Significance of TERT Promoter Mutations in Cancer: A Cohort Study and a Meta-Analysis.BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Carcinoma in Chinese Patients.Association of telomerase reverse transcriptase promoter mutations with clinicopathological features and prognosis of thyroid cancer: a meta-analysis.Clinical utility of TERT promoter mutations and ALK rearrangement in thyroid cancer patients with a high prevalence of the BRAF V600E mutation.Low Prevalence of Somatic TERT Promoter Mutations in Classic Papillary Thyroid CarcinomaTERT promoter Mutation and Its Association with Clinicopathological Features and Prognosis of Papillary Thyroid Cancer: A Meta-analysisTERT promoter mutations are a major indicator of recurrence and death due to papillary thyroid carcinomas.Prognostic effects of TERT promoter mutations are enhanced by coexistence with BRAF or RAS mutations and strengthen the risk prediction by the ATA or TNM staging system in differentiated thyroid cancer patients.Clinicopathological significance of TERT promoter mutation in papillary thyroid carcinomas: a systematic review and meta-analysis.TERT Promoter Mutations in Thyroid Cancer.Prognostic implication of BRAF and TERT promoter mutation combination in papillary thyroid carcinoma-A meta-analysis.Telomerase reverse transcriptase mutations are independent predictor of disease-free survival in Middle Eastern papillary thyroid cancer.Role of molecular markers to predict distant metastasis in papillary thyroid carcinoma: Promising value of TERT promoter mutations and insignificant role of BRAF mutations-a meta-analysis.Genome-wide profiling identifies the THYT1 signature as a distinctive feature of widely metastatic Papillary Thyroid Carcinomas.Downregulated expression of TSHR is associated with distant metastasis in thyroid cancer.TERT promoter mutations and their correlation with BRAF and RAS mutations in a consecutive cohort of 145 thyroid cancer cases.Clinicopathological Risk Factors for Distant Metastasis in Differentiated Thyroid Carcinoma: A Meta-analysis.Significant association between interleukin-10 gene polymorphisms and cervical cancer risk: a meta-analysis.Telomere Maintenance Mechanisms in Cancer.Coexistence of Promoter Mutations and the V600E Alteration and Its Impact on Histopathological Features of Papillary Thyroid Carcinoma in a Selected Series of Polish PatientsPapillary thyroid carcinoma with tall cell features is as aggressive as tall cell variant: a meta-analysis
P2860
Q26738705-6CCF33BA-6ED1-4B81-A9CC-2170D45A8FA6Q26770808-B825A1D2-C496-419D-9BDA-CA0B2DEA2F90Q26782322-86060EA4-EE02-422D-A2D6-36EA4753DA5CQ33656624-54E8B29B-E83E-4790-8E6E-94DF11A787D3Q33771707-078CEA27-C236-4B20-9E6E-16503E7BEB48Q35711083-AE83B14B-B44A-4E6F-BD6A-230B53110C4AQ35901458-18A178C0-66D8-403A-88B0-A88B9A7AF400Q35985808-1B7CA20E-189B-4D32-9B80-12949FDC6DC2Q36221232-17DB6DB3-D37A-43AE-A72B-5E165ABE17E0Q36560914-0319DD06-9929-4EEF-AD68-98227C3344C7Q36716977-F9A3FE09-4A02-4000-A259-B530DE78E703Q37408393-8A827326-9047-41C9-827B-C024CCAC8C8CQ38383121-4C9694B7-6CEC-4677-99B2-8299DCF6485DQ38416278-DD60639C-46A6-440F-8620-4A28B1911610Q38687220-51908C81-61A2-4D9C-81FA-90B7CC79EBDAQ38744769-51E319D4-03E1-4E99-B17E-0442EB186150Q39407370-6070F3A9-DBC3-4F5E-8797-DA7FF1E6CC22Q47266315-3DF62120-4B4E-4F2F-8D53-1C6FE88F6D6DQ47646209-53384D76-DB58-46FF-BCB2-BB6A9A27D23EQ49197249-7A04B868-7AB6-4C4C-A30C-841FF8795A25Q49364377-6C5A2AE9-824F-46F1-820B-604E2557209DQ50053390-B41521B3-0064-4519-8133-DE64D47F91F4Q50075399-63874E9A-BEA9-4605-AB2A-58F2F27A94F7Q55085960-C1F88151-FA1A-423E-830C-CC558EA1D851Q55443450-EFAAF0B6-816E-4218-A38B-482FEFBCC32BQ57210092-3CF75BF1-FE93-48AE-AD48-7016912F7C83Q57818907-4A342248-AF09-4403-93B4-D4A16B48C88C
P2860
TERT promoter mutations are associated with distant metastases in papillary thyroid carcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
TERT promoter mutations are as ...... n papillary thyroid carcinoma.
@en
TERT promoter mutations are as ...... n papillary thyroid carcinoma.
@nl
type
label
TERT promoter mutations are as ...... n papillary thyroid carcinoma.
@en
TERT promoter mutations are as ...... n papillary thyroid carcinoma.
@nl
prefLabel
TERT promoter mutations are as ...... n papillary thyroid carcinoma.
@en
TERT promoter mutations are as ...... n papillary thyroid carcinoma.
@nl
P2093
P50
P356
P1476
TERT promoter mutations are as ...... n papillary thyroid carcinoma.
@en
P2093
Andrea Frasoldati
Moira Ragazzi
Simonetta Piana
P304
P356
10.1530/EJE-14-0837
P577
2015-01-12T00:00:00Z